Company intelligence / Profile preview

Oncurious NV

Ownership: Private
Employees: ~50
Development stage: Phase 1

Overview

Oncurious NV develops innovative oncology treatments focused on enhancing T cell activity within the tumor microenvironment. Its lead clinical program was TB‑403, a humanized monoclonal antibody against PlGF for pediatric brain cancers. The company has also advanced a pipeline of next-generation cancer immunotherapies targeting immune-excluded solid tumors using multi-specific biologics. In recent years, some assets have been licensed out or transferred to partners such as VIB for further development.

Therapeutic areas: Oncology
Modalities: Monoclonal antibodies (mAbs)Multi-specific biologics/immunotherapies
Industry: Biotech

Drug pipeline

1 asset

TB-403

Phase 1

Indications: Medulloblastoma

Partnerships

VIB Discovery Sciences/VIB research institute—collaborative R&D partner for pipeline development and scientific input; profit-sharing/licensing agreements on certain assets.

Beyond the preview

Go deeper on Oncurious NV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncurious NV.

Explore the full profile